Corporate & Securities Law

To Naught
Rambus, having participated in proceedings leading to the industry standard for dynamic memory chips, patented portions of it. As chronicled in the Patent Prospector, that bit of seeming unseemliness has not been altogether well received during Rambus' patent enforcement campaigns...

Rambus Rambles
Memory chip patent holder Rambus saw its stock soar 39% on news that a San Jose jury dismissed charges from competitors Hynix, Micron, and Nanya, that Rambus rigged the playing field by getting patents on the SDRAM memory standard...

The Limited Legal Impact of the D.C. Circuits Rambus Decision
Deception in the standard setting process is anticompetitive if the deception leads to increased market power. In other words, the conceptual sequence of events is as follows:Deception:Reliance by the SSO on the deception in the standards-adoption decisionMarket power gain through inclusion in the standard...

Patently-O Bits and Bytes No. 30
Standard Setting & Patents: The Court of Appeals for the District of Columbia has overturned an FTC monopolization ruling against Rambus. The FTC had found that Rambus deceptively failed to disclose its patentable DRAM technology to the JEDEC standard-setting body...

Court reverses FTC in Rambus ruling, but patent holders should still use caution with proposals to standard-setting organizations
On April 22, the U.S. Court of Appeals for the D.C. Circuit reversed a decision of the Federal Trade Commission and held that a company’s failure to disclose its patents to a standard-setting organization who was considering adoption of the patented technology did not - by itself - violate antitrust laws...

D.C. Circuit Overturns FTC Rambus Decision
There has been an important decision in the antitrust litigation against Rambus for failing to disclose patents to JEDEC, a standard setting body (SSO). In Rambus v. FTC, No. 07-1086 (D...

Unwed Fathers' Rights in Adoption
Landmark Cases in Adoption Law Shape Law with respect to Unwed Fathers

Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.

Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.

DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Sony
to Pay $18.5 Million For Patent Infringment

Qualcomm Settles Patent Suit for $891 Million

The Princeton Review
$2.6 million settlement reached in patent infringement case.